Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205

NCT07634510 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: MWX205
DRUG: Placebo

Sponsor

Shanghai Minwei Biotechnology Co., Ltd